【Acer】Board of Directors Approves Spin-off of Biomedical Business Unit to Establish a Wholly-Owned Subsidiary
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Acer's Board of Directors has approved the spin-off of its biomedical business unit to establish a new wholly-owned subsidiary, Acer Biomedical Co., Ltd., effective June 29, 2026. This move aims to foster internal innovation and attract strategic partners.